Patents by Inventor Nancy Cook Bruns

Nancy Cook Bruns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REDUCING THE RISK OF CARDIOVASCULAR EVENTS
    Publication number: 20210023088
    Abstract: Combination therapy with rivaroxaban and aspirin successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease.
    Type: Application
    Filed: October 2, 2020
    Publication date: January 28, 2021
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Nancy Cook Bruns, Frank Misselwitz, John Eikelboom, Stuart J. Connolly, Salim Yusuf
  • Reducing the risk of cardiovascular events
    Patent number: 10828310
    Abstract: Combination therapy with rivaroxaban and aspirin successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: November 10, 2020
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Nancy Cook Bruns, Frank Misselwitz, John William Andrew Eikelboom, Stuart J. Connolly, Salim Yusuf
  • REDUCING THE RISK OF CARDIOVASCULAR EVENTS
    Publication number: 20190240231
    Abstract: Combination therapy with rivaroxaban and aspirin successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 8, 2019
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Nancy Cook Bruns, Frank Misselwitz, John William Andrew Eikelboom, Stuart J. Connolly, Salim Yusuf